Stock V3V VITA 34 AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings VITA 34 AG

Equities

V3V

DE000A0BL849

Real-time Estimate Tradegate
Other stock markets
 12:37:30 30/04/2024 BST 		5-day change 1st Jan Change
5.15 EUR +0.98% Intraday chart for VITA 34 AG +3.96% +0.19%
2023 VITA 34 AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 VITA 34 AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • Sales forecast by analysts have been recently revised upwards.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Low profitability weakens the company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
VITA 34 AG Stock VITA 34 AG
+0.19% 95.25M -
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.58% 85.02B
B-
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+15.05% 82.37B
C+
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.49% 29.29B
C+
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-10.17% 17.21B
B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.39% 16.7B
A-
PURE HEALTH HOLDING Stock Pure Health Holding
-31.05% 11.8B - -
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+2.40% 12.15B
A-
DAVITA INC. Stock DaVita Inc.
+31.86% 12.12B
B-
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-2.37% 12.13B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. V3V Stock
  4. Ratings VITA 34 AG